Mumbai, February 22, 2018: Pharma significant Lupin declared the dispatch of its Memantine Hydrochloride Broadened Discharge Containers, 7mg, 14mg, 21mg,28mg having gotten an endorsement from the Assembled States Sustenance and Medication Organization (FDA) prior.
Lupin’s Memantine Hydrochloride ER containers 7mg, 14mg, 21mg, 28mg are the nonexclusive counterparts of Allergan’s Namenda XR capsiles.
It is demonstrated for the treatment of direct to serious dementia of the Alzheimer’s write. Memantine Hydrochloride ER cases 7mg, 14mg, 21mg, 28mg had yearly offers of roughly USD 936 million in the US.
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…